---
document_datetime: 2023-09-21 20:07:29
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/sovaldi-epar-all-authorised-presentations_en.pdf
document_name: sovaldi-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.4417571
conversion_datetime: 2025-12-30 12:38:21.417257
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Pack size           |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|---------------------|
| EU/1/13/894/001  | Sovaldi           | 400 mg     | Film-coated tablet    | Oral use                  | bottle (HDPE)         | 28 tablets          |
| EU/1/13/894/002  | Sovaldi           | 400 mg     | Film-coated tablet    | Oral use                  | bottle (HDPE)         | 84 (3 x 28) tablets |
| EU/1/13/894/003  | Sovaldi           | 200 mg     | Film-coated tablet    | Oral use                  | bottle (HDPE)         | 28 tablets          |
| EU/1/13/894/004  | Sovaldi           | 150 mg     | Coated granules       | Oral use                  | sachet (PET/ALU/PE)   | 28 sachets          |
| EU/1/13/894/005  | Sovaldi           | 200 mg     | Coated granules       | Oral use                  | sachet (PET/ALU/PE)   | 28 sachets          |